期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 57, 期 3, 页码 1157-1162出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.01669-12
关键词
-
资金
- Ministerio de Sanidad y Consumo, the Instituto de Salud Carlos III (Madrid, Spain) [INT10/219]
- Spanish Network for Research in Infectious Diseases (REIPI) [RD06/0008]
- Fondo de Investigaciones Sanitarias (Madrid, Spain) [FIS 080268, 1101131]
- Fundacion Maximo Soriano Jimenez (Barcelona, Spain)
- Departament de Salut de la Generalitat de Catalunya, Barcelona, Spain
- Astellas
- Astra-Zeneca
- Aventis
- Bristol-Myers Squibb
- Galderma
- Gilead Sciences
- Janssen-Cilag
- MSD
- Novartis
- Pfizer
- ViiV Healthcare
- Abbott
- Boehringer-Ingelheim
- Cubist
- Glaxo Smith Kline
- Roche
- Theravance
- AstraZeneca
Concerns have recently emerged about the potency and the quality of generic vancomycin (VAN) products approved for use in humans, based on experiments in a neutropenic mouse thigh infection model. However, other animal models may be more appropriate to decipher the bactericidal activities of VAN generics in vivo and to predict their efficacy in humans. We aimed to compare the bactericidal activities of six generic VAN products currently used in France (Mylan and Sandoz), Spain (Hospira), Switzerland (Teva), and the United States (Akorn-Strides and American Pharmaceutical Products [APP]) in a rabbit model of aortic valve endocarditis induced by 8 x 10(7) CFU of methicillin-resistant Staphylococcus aureus (MRSA) strain COL (VAN MIC, 1.5 mu g/ml). In vitro, there were no significant differences in the time-kill curve studies performed with the six generic VAN products. Ten rabbits in each group were treated with intravenous (i.v.) VAN, 60 mg/kg of body weight twice a day (b.i.d.) for 4 days. Mean peak serum VAN levels, measured 45 min after the last injection, ranged from 35.5 (APP) to 45.9 mu g/ml (Teva). Mean trough serum VAN levels, measured 12 h after the last injection, ranged from 2.3 (Hospira) to 9.2 (APP) mu g/ml. All generic VAN products were superior to controls (no treatment) in terms of residual organisms in vegetations (P< 0.02 for each comparison) and in the spleen (P< 0.005 for each comparison). Pairwise comparisons of generic VAN products found no significant differences. In conclusion, a stringent MRSA endocarditis model found no significant differences in the bactericidal activities of six generic VAN products currently used in Europe and America.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据